Popit and MediService join forces to change how Swiss patients take medicines.
Espoo, Finland – Popit, a pioneer in improving medication adherence, and MediService, a Swiss specialty pharmacy, are joining forces to revolutionize medication adherence for patients in Switzerland. With this collaboration, the Swiss pharmacy with a focus on caring for people with chronic and rare diseases will offer Popit to their patients taking anticoagulants to further improve patient compliance and outcomes.
This exciting collaboration combines Popit’s innovative medication adherence technology with MediService’s longstanding expertise in home pharmacy care. The partnership underscores the ongoing changes seen in treatment: taking medicine is going digital and patients are increasingly relying on new, convenient telehealth services.
The goal of this project is to empower patients to have more control over outcomes. For this, Popit and MediService provide patients with a practical digital tool that not only brings unparalleled convenience and ease to their daily medication regimen but also removes the burden of worry and uncertainty. This way patients can focus on living their best lives with the peace of mind they deserve.
Anticoagulants are used for chronic cardiovascular conditions that are some of the leading causes of death and disability worldwide. In the EU alone, around 9% of cardiovascular disease (CVD) cases can be attributed to the fact that only about half of CVD patients continue to take prescribed life-saving medicines. Rivaroxaban is the active ingredient in the blood thinner drug commonly used to treat these conditions. It is taken orally at regular intervals and, like any medication for chronic conditions, relies on patients taking it as prescribed for it to achieve the expected results.
Patients prescribed rivaroxaban will be offered free of charge Popit’s small sensor device and mobile app that seamlessly monitors and reminds them of their daily medication by using patented technology. Additionally, they will receive timely and personalized in-app messages, and in-app access to resources to stay educated and engaged in treatment. With the help of Popit, patients can prevent missed doses and achieve better treatment results.
At Popit, we understand that managing a chronic condition can be difficult for patients. – Timo HeikkiläCOO of Popit
“We are therefore very excited to partner with MediService to offer our innovative technology to patients in Switzerland who are taking anticoagulants,” said Timo Heikkilä, COO. “We believe that everyone deserves the best possible health outcomes, and our technology can help patients stay on track with their medication regimen, avoid missed doses, and achieve better health . By working together, we put patients at the center of their care and empower them to take control of their health and well-being.”
For more information about the release, please contact Timo Heikkilä, +358(0)504873728.
Popit is a pioneer in improving patient compliance through smart pill-tracking device. The The company is focused on improving adherence through the digitization of medicine, a huge opportunity that benefits patients, patient support programs, healthcare payers, and the pharmaceutical industry. Popit works with the world’s leading pharmaceutical companies in implementing this vision.
At MediService, we’ve made it our mission to make life easier for chronically ill patients at home: Healthy@Home! In addition to delivering prescription medication, we also provide a variety of specialized services, access to health information, and tips and tricks on how to integrate medications into everyday life.
